NASDAQ$TLRY
Tilray Brands Inc · Q1 2025 earnings
Q1 2025 earnings · · Investor relations
Briefing
Achieved 13% year-over-year growth with record Q1 net revenue of $200 million.
Tilray Brands reported a 13% year-over-year revenue growth, reaching a record $200 million in net revenue for Q1 2025. The company's gross margin increased by over 500 basis points, representing a 20% year-over-year growth. Tilray Beverages experienced a 132% net revenue growth, and German medical cannabis flower revenue increased by 50% following legalization.
- Tilray Brands achieved 13% year-over-year revenue growth.
- Record Q1 net revenue of $200 million was generated.
- Gross margin increased over 500 basis points, a 20% year-over-year growth.
- Tilray Beverages net revenue grew by 132%.
Headline financials
Revenue & EPS history
Tilray · Revenue · Quarterly
$200M
Revenue by segment
Tilray · $152M total across 4 segments · Q3 2022
- Distribution$62.5M-11.0%41.2%
- Cannabis$55M+31.9%36.2%
- Beverage$19.6M+64.1%12.9%
- Wellness$14.7M—9.7%
Forward guidance
Tilray anticipates improved regulatory changes in the cannabis industry following the upcoming U.S. Presidential elections, with both candidates expressing support for further legalization. The company is optimistic about future opportunities in the cannabis industry.
Tailwinds
- Anticipates improved regulatory changes in the cannabis industry following the upcoming U.S. Presidential elections.
- Both candidates have publicly confirmed their support for further legalization.
- Optimistic about the future of the cannabis industry.
- Dedicated to executing strategic plan to increase revenue.
- Dedicated to executing strategic plan to drive operational efficiencies, and improve margins and profitability
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2025
-2.1%
Avg return
Earnings day
-4.2%
Avg return
5 days after
-3.5%
Avg return
30 days after
34%
11 / 32 earnings
Positive
+27.4%
Q4 2023
Best reaction
-22.0%
Q3 2024
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q3 2026 | -2.9% | -9.2% | — | |
| Q2 2026 | +0.2% | +8.4% | -17.0% | |
| Q1 2026 | +21.2% | -7.0% | -27.9% | |
| Q3 2025 | -21.2% | -15.5% | -24.1% | |
| Q2 2025 | -13.9% | -13.9% | -27.0% | |
| Q1 2025 | +0.0% | -3.7% | -8.6% | |
| Q4 2024 | +9.8% | +1.6% | -7.1% | |
| Q3 2024 | -22.0% | -29.7% | -23.6% | |
| Q2 2024 | -14.5% | -20.1% | -19.2% | |
| Q1 2024 | -5.4% | -9.4% | -14.3% | |
| Q4 2023 | +27.4% | +50.6% | +39.3% | |
| Q3 2023 | -3.1% | -8.8% | +5.8% | |
| Q2 2023 | -5.4% | +7.5% | +2.7% | |
| Q1 2023 | -21.3% | -21.0% | -2.3% | |
| Q4 2022 | +12.0% | +19.6% | +17.5% | |
| Q3 2022 | -7.8% | -9.4% | -32.6% | |
| Q2 2022 | +15.0% | +6.9% | +7.8% | |
| Q1 2022 | -2.8% | -4.7% | -0.8% | |
| Q4 2021 | +21.1% | +14.8% | +5.4% | |
| Q3 2021 | +1.4% | +0.1% | -16.8% | |
| Q4 2020 | -21.7% | -24.1% | -26.8% | |
| Q2 2021 | +4.3% | +10.2% | +109.7% | |
| Q3 2020 | -13.5% | -20.6% | -17.8% | |
| Q2 2020 | -7.1% | -2.8% | -24.3% | |
| Q1 2020 | -4.0% | -0.1% | +24.6% | |
| Q4 2019 | -9.8% | -30.6% | -59.1% | |
| Q3 2019 | -4.5% | -9.1% | -13.6% | |
| Q2 2019 | -8.1% | -26.3% | -28.0% | |
| Q1 2019 | +5.2% | -1.7% | -12.4% | |
| Q4 2018 | -3.7% | -7.4% | -30.1% | |
| Q3 2018 | -9.8% | -2.6% | -33.4% | |
| Q2 2018 | +16.3% | +22.0% | +145.7% | |
| Q1 2018 | — | — | — | |
| Q4 2017 | — | — | — | |
| Q3 2017 | — | — | — | |
| Q2 2017 | — | — | — | |
| Q1 2017 | — | — | — | |
| Q4 2016 | — | — | — | |
| Q3 2016 | — | — | — | |
| Q2 2016 | — | — | — | |
| Q1 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q3 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q1 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q3 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2012 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2011 | — | — | — | |
| Q2 2011 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro